Literature DB >> 34850129

The nuclear and cytoplasmic activities of RNA polymerase III, and an evolving transcriptome for surveillance.

Alan C Kessler1, Richard J Maraia1.   

Abstract

A 1969 report that described biochemical and activity properties of the three eukaryotic RNA polymerases revealed Pol III as highly distinguishable, even before its transcripts were identified. Now known to be the most complex, Pol III contains several stably-associated subunits referred to as built-in transcription factors (BITFs) that enable highly efficient RNA synthesis by a unique termination-associated recycling process. In vertebrates, subunit RPC7(α/β) can be of two forms, encoded by POLR3G or POLR3GL, with differential activity. Here we review promoter-dependent transcription by Pol III as an evolutionary perspective of eukaryotic tRNA expression. Pol III also provides nonconventional functions reportedly by promoter-independent transcription, one of which is RNA synthesis from DNA 3'-ends during repair. Another is synthesis of 5'ppp-RNA signaling molecules from cytoplasmic viral DNA in a pathway of interferon activation that is dysfunctional in immunocompromised patients with mutations in Pol III subunits. These unconventional functions are also reviewed, including evidence that link them to the BITF subunits. We also review data on a fraction of the human Pol III transcriptome that evolved to include vault RNAs and snaRs with activities related to differentiation, and in innate immune and tumor surveillance. The Pol III of higher eukaryotes does considerably more than housekeeping. Published by Oxford University Press on behalf of Nucleic Acids Research 2021.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34850129      PMCID: PMC8643620          DOI: 10.1093/nar/gkab1145

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  197 in total

1.  Direct activation of RNA polymerase III transcription by c-Myc.

Authors:  Natividad Gomez-Roman; Carla Grandori; Robert N Eisenman; Robert J White
Journal:  Nature       Date:  2003-01-16       Impact factor: 49.962

Review 2.  RNA Polymerase III as a Gatekeeper to Prevent Severe VZV Infections.

Authors:  Madalina E Carter-Timofte; Søren R Paludan; Trine H Mogensen
Journal:  Trends Mol Med       Date:  2018-08-13       Impact factor: 11.951

3.  Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML.

Authors:  Marianne Bach Treppendahl; Xiangning Qiu; Alexandra Søgaard; Xiaojing Yang; Cecilie Nandrup-Bus; Christoffer Hother; Mette Klarskov Andersen; Lars Kjeldsen; Lars Möllgård; Lars Möllgaard; Eva Hellström-Lindberg; Johan Jendholm; Bo T Porse; Peter A Jones; Gangning Liang; Kirsten Grønbæk
Journal:  Blood       Date:  2011-11-04       Impact factor: 22.113

4.  Recycling of the general transcription factors during RNA polymerase II transcription.

Authors:  L Zawel; K P Kumar; D Reinberg
Journal:  Genes Dev       Date:  1995-06-15       Impact factor: 11.361

5.  Mutations in the RNA polymerase III subunit Rpc11p that decrease RNA 3' cleavage activity increase 3'-terminal oligo(U) length and La-dependent tRNA processing.

Authors:  Ying Huang; Robert V Intine; Amy Mozlin; Samuel Hasson; Richard J Maraia
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

6.  NF45 and NF90 regulate HS4-dependent interleukin-13 transcription in T cells.

Authors:  Patricia Kiesler; Paul A Haynes; Lingfang Shi; Peter N Kao; Vicki H Wysocki; Donata Vercelli
Journal:  J Biol Chem       Date:  2010-01-05       Impact factor: 5.157

7.  RNA binding activates RIG-I by releasing an autorepressed signaling domain.

Authors:  T H Dickey; B Song; A M Pyle
Journal:  Sci Adv       Date:  2019-10-02       Impact factor: 14.136

8.  Structural basis of RNA polymerase III transcription initiation.

Authors:  Guillermo Abascal-Palacios; Ewan Phillip Ramsay; Fabienne Beuron; Edward Morris; Alessandro Vannini
Journal:  Nature       Date:  2018-01-17       Impact factor: 49.962

9.  A tale of an A-tail: The lifeline of a SINE.

Authors:  Astrid M Roy-Engel
Journal:  Mob Genet Elements       Date:  2012-11-01

10.  vtRNA2-1/nc886 Produces a Small RNA That Contributes to Its Tumor Suppression Action through the microRNA Pathway in Prostate Cancer.

Authors:  Rafael Sebastián Fort; Beatriz Garat; José Roberto Sotelo-Silveira; María Ana Duhagon
Journal:  Noncoding RNA       Date:  2020-02-20
View more
  4 in total

Review 1.  Are We Studying Non-Coding RNAs Correctly? Lessons from nc886.

Authors:  Yong Sun Lee
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

2.  A cancer-associated RNA polymerase III identity drives robust transcription and expression of snaR-A noncoding RNA.

Authors:  Kevin Van Bortle; David P Marciano; Qing Liu; Tristan Chou; Andrew M Lipchik; Sanjay Gollapudi; Benjamin S Geller; Emma Monte; Rohinton T Kamakaka; Michael P Snyder
Journal:  Nat Commun       Date:  2022-05-30       Impact factor: 17.694

3.  Transcriptional response to VZV infection is modulated by RNA polymerase III in lung epithelial cell lines.

Authors:  Brianna M Doratt; Elizabeth Vance; Delphine C Malherbe; Mark T W Ebbert; Ilhem Messaoudi
Journal:  Front Cell Infect Microbiol       Date:  2022-07-25       Impact factor: 6.073

4.  Evolution of the RNA Cleavage Subunit C11/RPC10, and Recycling by RNA Polymerase III.

Authors:  Saurabh Mishra; Richard J Maraia
Journal:  J Cell Immunol       Date:  2022
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.